Reported 6,224,755 shares, up 3,481,256 (126.9%) from the prior quarter.
Reported value 155.3%; share count 126.9% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 1977000 |
| 2022-03-31 | 1005000 |
| 2022-06-30 | 1803000 |
| 2022-09-30 | 2937000 |
| 2022-12-31 | 2568748 |
| 2023-03-31 | 1729978 |
| 2023-06-30 | 2915011 |
| 2023-09-30 | 6170658 |
| 2023-12-31 | 25398364 |
| 2024-03-31 | 19578862 |
| 2024-06-30 | 13262352 |
| 2024-09-30 | 12370764 |
| 2024-12-31 | 19337168 |
| 2025-03-31 | 26505195 |
| 2025-06-30 | 28789445 |
| 2025-09-30 | 35576930 |
| 2025-12-31 | 23139501 |
| 2026-03-31 | 6708961 |
| 2026-06-30 | 10068644 |
| 2026-09-30 | 25708241 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Added | 6,224,755 | +3,481,256 (126.9%) | < 0.01% | $25,708,241 | 2026-11-13 | |
| Q2 2026 | Added | 2,743,499 | +558,170 (25.5%) | < 0.01% | $10,068,644 | 2026-08-13 | |
| Q1 2026 | Reduced | 2,185,329 | -3,472,249 (-61.4%) | < 0.01% | $6,708,961 | 2026-05-15 | |
| Q4 2025 | Reduced | 5,657,578 | -1,632,775 (-22.4%) | < 0.01% | $23,139,501 | 2026-02-13 | |
| Q3 2025 | Added | 7,290,353 | +1,600,741 (28.1%) | < 0.01% | $35,576,930 | 2025-11-14 | |
| Q2 2025 | Added | 5,689,612 | +679,179 (13.6%) | < 0.01% | $28,789,445 | 2025-08-15 | |
| Q1 2025 | Added | 5,010,433 | +2,149,906 (75.2%) | < 0.01% | $26,505,195 | 2025-05-15 | |
| Q4 2024 | Added | 2,860,527 | +983,326 (52.4%) | < 0.01% | $19,337,168 | 2025-02-14 | |
| Q3 2024 | Added | 1,877,201 | +108,889 (6.2%) | < 0.01% | $12,370,764 | 2024-11-14 | |
| Q2 2024 | Reduced | 1,768,312 | -195,465 (-10.0%) | < 0.01% | $13,262,352 | 2024-08-14 | |
| Q1 2024 | Reduced | 1,963,777 | -612,122 (-23.8%) | < 0.01% | $19,578,862 | 2024-05-15 | |
| Q4 2023 | Added | 2,575,899 | +1,769,277 (219.3%) | < 0.01% | $25,398,364 | 2024-02-13 | |
| Q3 2023 | Added | 806,622 | +416,393 (106.7%) | < 0.01% | $6,170,658 | 2023-11-15 | |
| Q2 2023 | Added | 390,229 | +130,862 (50.5%) | < 0.01% | $2,915,011 | 2023-08-14 | |
| Q1 2023 | Reduced | 259,367 | -73,804 (-22.2%) | < 0.01% | $1,729,978 | 2023-05-15 | |
| Q4 2022 | Added | 333,171 | +57,229 (20.7%) | < 0.01% | $2,568,748 | 2023-02-14 | |
| Q3 2022 | Added | 275,942 | +54,424 (24.6%) | < 0.01% | $2,937,000 | 2022-11-14 | |
| Q2 2022 | Added | 221,518 | +81,107 (57.8%) | < 0.01% | $1,803,000 | 2022-08-15 | |
| Q1 2022 | Added | 140,411 | +24,996 (21.7%) | < 0.01% | $1,005,000 | 2022-05-13 | |
| Q4 2021 | Added | 115,415 | +105,715 (1089.8%) | < 0.01% | $1,977,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
382 managers reported RECURSION PHARMACEUTICALS IN for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BlackRock Inc | Added | 53,478,879 | +3,174,188 | < 0.01% | $220,867,771 | 9 qtrs |
| ARK Investment Management LLC | Added | 44,745,025 | +3,407,393 | 1.06% | $184,796,952 | 22 qtrs |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Added | 35,812,145 | +4,680,546 | < 0.01% | $147,904,159 | 3 qtrs |
| STATE STREET CORPORATION | Reduced | 30,001,137 | -4,704,993 | < 0.01% | $123,904,696 | 22 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Added | 23,004,367 | +238,427 | < 0.01% | $95,008,036 | 3 qtrs |
| BAILLIE GIFFORD & CO | Reduced | 18,174,384 | -5,313,523 | 0.07% | $75,060,206 | 22 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 13,913,841 | +94,706 | < 0.01% | $57,473,770 | 22 qtrs |
| SOFTBANK GROUP CORP | Unchanged | 13,636,515 | 0 | 0.35% | $56,318,807 | 8 qtrs |
| FMR LLC | Added | 11,439,657 | +11,393,301 | < 0.01% | $47,245,782 | 22 qtrs |
| UBS Group AG | Reduced | 8,430,018 | -517,084 | < 0.01% | $34,815,974 | 22 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 13, 2026
- Filing type
- 13F-HR
- Position type
- CL A
Voting authority reported
- Sole
- 4,492,362
- Shared
- 0
- None
- 1,732,393
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.